Sat.Apr 16, 2022 - Fri.Apr 22, 2022

Satellite Bio launches with new approach to bioengineering tissues

Bio Pharma Dive

Backed by $110 million in venture funding, Satellite is led by Dave Lennon, formerly head of Novartis Gene Therapies

HCPs sound off on pharma marketing

World of DTC Marketing

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. Attitudes are indeed changing, but one need remains clear: access to data obtained during clinical and ongoing trials.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The physics of a singing saw


The eerie, ethereal sound of the singing saw has been a part of folk music traditions around the globe, from China to Appalachia, since the proliferation of cheap, flexible steel in the early 19th century.


US study finds high rates of unneeded antibiotic prescribing

Pharma Phorum

A study has found that there is still a very high level of inappropriate antibiotic prescribing to patients in the US, particularly to older and Black patients.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

A promising cancer drug leads Regeneron to reconsider its aversion to M&A

Bio Pharma Dive

Regeneron has agreed to purchase Checkmate Pharmaceuticals for $250 million, the first acquisition of a publicly traded company in the biotech's nearly 35-year history

Drugs 262

More Trending

Evidence suggests cancer is not as purely genetic as once thought


While cancer is a genetic disease, the genetic component is just one piece of the puzzle — and researchers need to consider environmental and metabolic factors as well, according to a research review by a leading expert at the University of Alberta.

Clinical trial evolution, innovation center of Oracle Health Sciences event

Outsourcing Pharma

The two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices. Clinical Development

GSK to test FDA's tough stance on anemia pills

Bio Pharma Dive

Unlike treatments from Akebia and FibroGen, GSK's drug hasn't been tied to a higher risk of heart problems, potentially easing the agency's concerns

Drugs 258

DTC Marketing strategy must be fluid

World of DTC Marketing

Before most drugs are launched, much time and effort are spent developing marketing plans and getting approval. However, given the rapid changes in the market and the realization that too many tactics are more hype than reality, fixed marketing plans are a waste of time.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Iowa State team receives XPRIZE Carbon Removal milestone award for innovative vision to combat cliamte change


AMES, Iowa – An Iowa State University research team that helped develop a demonstration-scale pyrolyzer capable of sequestering thousands of tons of carbon dioxide a year has received a prestigious milestone award from XPRIZE Carbon Removal, it was announced on Friday.

GSK goes for gold as FDA starts review of daprodustat

Pharma Phorum

GlaxoSmithKline says the FDA has started its review of daprodustat for anaemia associated with chronic kidney disease (CKD), as it strives to succeed where two other rivals in the HIF-PHI class have failed.

Drugs 99

Imara to reduce staff by 83% amid biotech shakeout

Bio Pharma Dive

The planned job cuts were announced days after Imara — one of three spinouts from the drug accelerator Cydan Development, stopped development of its top medicine

New coalition formed to raise awareness of sight loss

Pharma Times

‘The Eyes Have It’ partnership will highlight the importance of eye health


Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

An ocean in your brain: Interacting brain waves key to how we process information


LA JOLLA—(April 22, 2022) For years, the brain has been thought of as a biological computer that processes information through traditional circuits, whereby data zips straight from one cell to another.

Ampio slumps as FDA delivers knee osteoarthritis shock

Pharma Phorum

Ampio Pharma’s candidate therapy for knee osteoarthritis has been knocked back by the FDA, which will likely now require a new clinical trial of the drug before it will consider a review.

Gilead gets cell therapy boost with FDA clearance of Maryland factory

Bio Pharma Dive

The new site in Frederick, Maryland will be used to produce Yescarta, which this month won an expanded approval that substantially widens its market

DNA analysis uncovers new cancer treatment clues

Pharma Times

Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers

Lesser known ozone layer’s outsized role in planet warming


New research has identified a lesser-known form of ozone playing a big role in heating the Southern Ocean — one of Earth’s main cooling systems.

The largest pharma company in Europe calls for interoperability

Pharma Phorum

Ehab Youssef, area head of Europe North at Roche Pharmaceuticals, tells us why European countries need interoperability to ensure a more effective overall European healthcare system.

Bristol Myers scraps $2B Nektar partnership after trial failures

Bio Pharma Dive

The companies have halted testing in kidney and bladder cancer, one month after ending a skin cancer study. Nektar executives are now preparing plans to conserve cash

Trials 249

Advanced analytic tools can improve safety reporting: IQVIA

Outsourcing Pharma

An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting. Clinical Development

Water processing: light helps degrade hormones


Wherever people are living, hormones used in e.g. contraceptives or agriculture enter the wastewater. Steroid hormones, such as sex hormones and corticosteroids, may accumulate in the environment and adversely affect humans and animals, as they impair behavioral development and fertility.

Astellas takes $170m charge as it drops DMD gene therapies

Pharma Phorum

Astellas has said it will book a $170 million impairment charge in its fourth quarter results as a result of a decision to halt the development of three gene therapy candidates for Duchenne muscular dystrophy in preclinical development.

Troubling data leads a biotech to pull its prized drug from market and FDA review

Bio Pharma Dive

Early analysis of a key clinical trial showed a potentially increased risk of death in cancer patients who received a combination treatment that included TG Therapeutics' approved medicine, Ukoniq

Moderna’s bivalent COVID-19 booster offers improved protection against Omicron

BioPharma Reporter

Modernaâs bivalent COVID-19 booster vaccine candidate, mRNA-1273.211, demonstrated superior neutralizing titers compared to the original mRNA-1273 booster dose against all variants of concern, including Omicron, according to data released by the company this week. Bio Developments

Light-controllable time-domain metasurface for dynamic harmonic manipulation


Metasurfaces are artificial array structures consisting of subwavelength unit cells arranged on a specific two-dimensional surface. Dynamic, reconfigurable metasurfaces are an excellent way to manipulate electromagnetic (EM) waves flexibly. Credit: Zhang et al., doi 10.1117/1.AP.4.2.025001.


Digital therapy for osteoarthritis tops other methods, says study

Pharma Phorum

A meta-analysis of published studies looking at web- app- or telehealth-based therapy for osteoarthritis has concluded that they outperform standard approaches to care.

Drug price hikes moderate as rebates rise, report finds

Bio Pharma Dive

List prices for branded medicines rose by nearly 5% last year, according to IQVIA, a figure that fell to 1% after accounting for rebates and discounts

RoboBurger: America’s First Burger Vending Machine


Newark, New Jersey-based RoboBurger claims to have created America’s first burger vending machine and is now looking to expand.

Cancer: Sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion


BIRMINGHAM, Ala. – For more than two decades, University of Alabama at Birmingham researcher Susan Bellis, Ph.D., has studied how the addition of sialic acid to various proteins increases cancer resistance and oncogenicity. Credit: UAB BIRMINGHAM, Ala. –

FDA starts speedy review of Enhertu in lung cancer

Pharma Phorum

AstraZeneca and Daiichi Sankyo should only have to wait for six months to hear from the FDA if it will approve their HER2 drug Enhertu for non-small cell lung cancer (NSCLC) and add to its current uses in breast and gastric cancer.

Sales 87